An international team of microbiologists and immunologists has found that commensal gut bacteria develop resistance to antibacterial therapies for infections. In their study, reported in the journal Science Translational Medicine, the group monitored and tested the gut biomes of patients undergoing long-term antibacterial treatment for tuberculosis.